Graham McLean Purchases 1,000 Shares of Fisher & Paykel Healthcare Co. Limited (ASX:FPH) Stock

Fisher & Paykel Healthcare Co. Limited (ASX:FPHGet Free Report) insider Graham McLean acquired 1,000 shares of the stock in a transaction that occurred on Monday, February 17th. The shares were bought at an average price of A$32.30 ($20.71) per share, with a total value of A$32,300.00 ($20,705.13).

Fisher & Paykel Healthcare Stock Performance

The company has a current ratio of 1.83, a quick ratio of 0.79 and a debt-to-equity ratio of 10.75. The stock has a market capitalization of $20.55 billion, a PE ratio of 157.79, a P/E/G ratio of 4.47 and a beta of 0.42.

Fisher & Paykel Healthcare Increases Dividend

The firm also recently declared a Interim dividend, which was paid on Tuesday, December 17th. Shareholders of record on Tuesday, December 17th were given a $0.167 dividend. This is a boost from Fisher & Paykel Healthcare’s previous Interim dividend of $0.17. This represents a yield of 0.49%. The ex-dividend date was Wednesday, December 4th. Fisher & Paykel Healthcare’s dividend payout ratio is 180.95%.

About Fisher & Paykel Healthcare

(Get Free Report)

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.

Further Reading

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.